ElucidVivo A.3 vs 1CMR Pro
AI Verdict
Choose ElucidVivo A.3 if…
Choose ElucidVivo A.3 if your primary need is detailed, AI-powered quantitative analysis of arterial plaque composition and stability from CT angiography. This tool is ideal for stratifying atherosclerosis patients and optimizing treatment decisions by visualizing and measuring specific plaque characteristics like Lipid-Rich Necrotic Core, validated against histology. It also provides derived fractional flow reserve (FFRct) to further inform care.
View ElucidVivo A.3 →Choose 1CMR Pro if…
Choose 1CMR Pro if you require highly precise and consistent AI-enhanced cardiac MRI reporting, focusing on automated volumetric and functional measurements. This software is best suited for institutions seeking to improve the speed and accuracy of cardiac MRI analysis, with the added benefit of local data processing to ensure patient data remains within your institution. Its transparent and editable contours also allow for clinician control and review.
View 1CMR Pro →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | ElucidVivo A.3 | 1CMR Pro |
|---|---|---|
| Pricing | Unknown | Contact for pricing |
| Deployment | Cloud and on-premise secure deployment. | On-premise (software installed on hospital's own computer, processing data locally via a secure web-based platform) |
| FDA Status | Cleared AI-estimated | Cleared AI-estimated |
| HIPAA | Yes AI-estimated | Unknown |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
1CMR ProTool B, 1CMR Pro, emphasizes 'transparent and editable contours for clinician control' and 'human-in-the-loop' editing, which are crucial for building trust and empowering users in AI-driven diagnostic tools. While Tool A offers rich visualization features, Tool B's explicit focus on clinician oversight and control suggests a potentially more user-friendly and trustworthy experience for complex diagnostic reporting.
Clinical Value
ElucidVivo A.3Tool A, ElucidVivo A.3, offers a novel and highly specialized diagnostic capability by providing quantitative analysis of arterial plaque composition and stability, validated against histology, and deriving fractional flow reserve (FFRct) from CT images. This unique insight into plaque vulnerability directly impacts treatment decisions and has demonstrated a 40% improvement in predictive accuracy for adverse events. While Tool B significantly improves the precision and efficiency of standard CMR analysis, Tool A's breakthrough in providing new types of predictive insights for atherosclerosis management represents a more profound clinical advancement.
Pricing & Value
ElucidVivo A.3Both tools require direct contact for pricing information, making a direct cost comparison difficult. However, ElucidVivo A.3 (Tool A) has a significant advantage with the recent establishment of a Category I CPT code for its quantitative coronary plaque analysis. This ensures widespread reimbursement from major payers, providing a clear and strong path to financial value for adopting healthcare institutions.
Enterprise Readiness
1CMR ProTool B, 1CMR Pro, demonstrates stronger enterprise readiness through its explicit on-premise deployment with local data processing, ensuring no patient data leaves the institution. Furthermore, its ISO 27001 certification provides a concrete assurance of robust security management, which is a significant advantage for healthcare organizations with strict data privacy and governance requirements.
Innovation
ElucidVivo A.3Tool A, ElucidVivo A.3, exhibits a higher degree of innovation by introducing a novel and highly specialized diagnostic capability for arterial plaque characterization and FFRct derivation from CT, validated against histology. This provides new predictive insights for atherosclerosis management and has led to a new CPT code, indicating a significant breakthrough in non-invasive cardiovascular assessment.
Support & Docs
1CMR ProWhile neither tool provides extensive public details on support and documentation in the initial facts, a job description for an Application Support role at Mycardium AI (Tool B) outlines specific responsibilities for technical support, troubleshooting, and integration. This suggests a dedicated and structured support system is in place for 1CMR Pro, offering more concrete evidence of its support infrastructure compared to the general expectation for enterprise solutions for ElucidVivo A.3.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | ElucidVivo A.3 | 1CMR Pro |
|---|---|---|
| Product Name | ElucidVivo A.3 | 1CMR Pro |
| Company | Elucid Bioimaging | Mycardium AI Limited |
| Primary Imaging Modality | CT angiography | Cardiac MRI |
| Key Analysis Focus | Quantitative analysis of arterial plaque composition and stability | AI-enhanced Cardiac MRI Reporting, automated volumetric and functional measurements |
| Specific Quantified Metrics | Lipid-Rich Necrotic Core (LRNC), matrix, and calcifications from CT images; fractional flow reserve (FFRct) | Automated volumetric and functional measurements |
| Data Processing Location | Not specified | Local data processing (no patient data transmitted beyond institution) |
| Precision/Accuracy Claim | Validated on ground-truth histology | Up to 40% more precise measurements; achieves up to 40% higher precision than manual analysis |
| Specialties | Cardiology, Radiology, Vascular Surgery | Cardiology, Radiology |
Videos
Demos, reviews, and walkthroughs featuring ElucidVivo A.3 and 1CMR Pro.